Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / ZNTL - Zentalis Pharmaceuticals appoints Kimberly Blackwell as top boss

ZNTL - Zentalis Pharmaceuticals appoints Kimberly Blackwell as top boss

Zentalis Pharmaceuticals Inc.
Clinical-stage biotech Zentalis Pharmaceuticals (NASDAQ:ZNTL) on Monday appointed board member Kimberly Blackwell as its CEO, replacing Anthony Sun. Before joining ZNTL, Blackwell was chief medical officer at Tempus, a privately held data-providing precision medicine company. She was a vice president at Eli Lilly (LLY) prior to that. Anthony Sun will remain CEO of ZNTL's joint venture, Zentera Therapeutics. ZNTL also said board member Dave Johnson had been appointed as chairman. Separately, ZNTL on Monday priced its underwritten offering of 10.3M shares at an offering price of $19.38/share for total gross proceeds of ~$200.2M. ZNTL stock +21.1% to $24.87 in morning trade.

For further details see:

Zentalis Pharmaceuticals appoints Kimberly Blackwell as top boss
Stock Information
Company Name: Zentalis Pharmaceuticals Inc.
Stock Symbol: ZNTL
Market: NASDAQ
Website: zentalis.com
Menu
ZNTL ZNTL Quote ZNTL Short ZNTL News ZNTL Articles ZNTL Message Board
Get ZNTL Alerts

News, Short Squeeze, Breakout and More Instantly...